Kaye Jack
Director at QURE; Director at KERYX BIOPHARMACEUTICALS INC
- Sold, on record
- $3.2M
- Dollars the filings state
- Form 4 sales
- 17
- Latest Jun 30, 2026
- Form 144 notices
- 6
- Proposed sales
- Quarters with a sale
- 4 of the last 8
- 7 days with a sale in that time
- Companies
- 2
- Filed as an executive or holder
Companies
- QUREuniQure N.V.Director
- KERYX BIOPHARMACEUTICALS INCDirector
Sales by reason
3
Routine
8
Plan not stated
3
No plan
3
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- QURE89,292 shares
- KERYX BIOPHARMACEUTICALS INC45,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- Jun 30, 2026Unusual
Sold 44.9% of their holdings
$983k21,167 shares at $46.44
- Jun 30, 2026Notice
Filed a notice to sell 21,167 shares
$983k21,167 shares
- Jun 17, 2026Routine
Sold 16.9% of their holdings
$225k5,295 shares at $42.57
- Jun 17, 2026Notice
Filed a notice to sell 5,295 shares
$225k5,295 shares
- Jun 11, 2026No plan
Sold 7.1% of their holdings
$54k1,993 shares at $27.06
- Jun 11, 2026Notice
Filed a notice to sell 1,993 shares
$54k1,993 shares
- Jun 3, 2026Routine
Sold 11.5% of their holdings
$79k2,645 shares at $30.01
- Jun 3, 2026Notice
Filed a notice to sell 2,645 shares
$79k2,645 shares
- Jan 9, 2026Routine
Sold 23.8% of their holdings
$174k6,390 shares at $27.28
- Jan 9, 2026Notice
Filed a notice to sell 6,390 shares
$174k6,390 shares
10 of 23
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 2, 2026 | QURE | Director | Sold | 21,167 | $46.44 | $983k | 25,996 | SEC |
| Jun 30, 2026 | Jul 2, 2026 | QURE | Director | Exercised or settledStock Option (Right to Buy) | 21,167 | 0 | SEC | ||
| Jun 30, 2026 | Jul 2, 2026 | QURE | Director | Exercised options | 21,167 | $23.44 | $496k | 43,056 | SEC |
| Jun 17, 2026 | Jun 22, 2026 | QURE | Director | Sold | 5,295 | $42.57 | $225k | 25,996 | SEC |
| Jun 17, 2026 | Jun 22, 2026 | QURE | Director | Exercised or settledStock Option (Right to Buy) | 5,295 | 0 | SEC | ||
| Jun 17, 2026 | Jun 22, 2026 | QURE | Director | Exercised options | 5,295 | $31.71 | $168k | 31,291 | SEC |
| Jun 11, 2026 | Jun 12, 2026 | QURE | Director | Sold | 1,993 | $27.06 | $54k | 25,996 | SEC |
| Jun 10, 2026 | Jun 12, 2026 | QURE | Director | AwardedStock Option (Right to Buy) | 13,980 | 13,980 | SEC | ||
| Jun 10, 2026 | Jun 12, 2026 | QURE | Director | Awarded | 7,550 | 27,989 | SEC | ||
| Jun 3, 2026 | Jun 5, 2026 | QURE | Director | Sold | 2,645 | $30.01 | $79k | 20,439 | SEC |
| Jun 3, 2026 | Jun 5, 2026 | QURE | Director | Exercised or settledStock Option (Right to Buy) | 2,645 | 0 | SEC | ||
| Jun 3, 2026 | Jun 5, 2026 | QURE | Director | Exercised options | 2,645 | $16.04 | $42k | 23,084 | SEC |
| Jan 9, 2026 | Jan 12, 2026 | QURE | Director | Sold | 6,390 | $27.28 | $174k | 20,439 | SEC |
| Jan 9, 2026 | Jan 12, 2026 | QURE | Director | Exercised or settledStock Option (Right to Buy) | 6,390 | 0 | SEC | ||
| Jan 9, 2026 | Jan 12, 2026 | QURE | Director | Exercised options | 6,390 | $19.39 | $124k | 26,829 | SEC |
| Jan 2, 2026 | Jan 6, 2026 | DYAI | Director | Exercised or settledRestricted Stock Unit | 21,552 | 0 | SEC | ||
| Jan 2, 2026 | Jan 6, 2026 | DYAI | Director | Exercised options | 21,552 | 81,201 | SEC | ||
| Jan 2, 2026 | Jan 6, 2026 | DYAI | Director | AwardedStock Option | 107,394 | 39,894 | SEC | ||
| Nov 4, 2025 | Nov 6, 2025 | QURE | Director | Sold | 38,810 | $30.34 | $1.2M | 20,439 | SEC |
| Nov 4, 2025 | Nov 6, 2025 | QURE | Director | Exercised or settledStock Option (Right to Buy) | 38,810 | 0 | SEC | ||
| Nov 4, 2025 | Nov 6, 2025 | QURE | Director | Exercised options | 38,810 | $9.88 | $384k | 38,249 | SEC |
| Jun 20, 2025 | Jun 24, 2025 | QURE | Director | Sold | 2,112 | $14.45 | $31k | 20,439 | SEC |
| Jun 11, 2025 | Jun 13, 2025 | QURE | Director | AwardedStock Option (Right to Buy) | 15,630 | 15,630 | SEC | ||
| Jun 11, 2025 | Jun 13, 2025 | QURE | Director | Awarded | 7,970 | 22,551 | SEC | ||
| Mar 5, 2025 | Mar 7, 2025 | DYAI | Director | Exercised or settledStock Option | 30,000 | 0 | SEC | ||
| Mar 5, 2025 | Mar 7, 2025 | DYAI | Director | Exercised options | 30,000 | $1.33 | $40k | 87,166 | SEC |
| Mar 5, 2025 | Mar 7, 2025 | DYAI | Director | Withheld for tax | 27,517 | $1.45 | $40k | 59,649 | SEC |
| Jan 2, 2025 | Jan 7, 2025 | DYAI | Director | Exercised or settledRestricted Stock Unit | 23,585 | 0 | SEC | ||
| Jan 2, 2025 | Jan 7, 2025 | DYAI | Director | Exercised options | 23,585 | 57,166 | SEC | ||
| Jan 2, 2025 | Jan 7, 2025 | DYAI | Director | AwardedStock Option | 89,052 | 21,552 | SEC | ||
| Jun 19, 2024 | Jun 21, 2024 | QURE | Director | AwardedStock Option (Right to Buy) | 15,840 | 15,840 | SEC | ||
| Jun 19, 2024 | Jun 21, 2024 | QURE | Director | Awarded | 8,080 | 14,581 | SEC | ||
| Jun 13, 2024 | Jun 17, 2024 | QURE | Director | Sold | 2,218 | $5.16 | $11k | 6,501 | SEC |
| Jan 3, 2024 | Jan 4, 2024 | DYAI | Director | Exercised or settledRestricted Stock Unit | 27,174 | 0 | SEC | ||
| Jan 3, 2024 | Jan 4, 2024 | DYAI | Director | Exercised options | 27,174 | 33,581 | SEC | ||
| Jan 2, 2024 | Jan 4, 2024 | DYAI | Director | AwardedStock Option | 91,085 | 23,585 | SEC | ||
| Jun 23, 2023 | Feb 6, 2024 | QURE | Director | Gift | 25,400 | 8,719 | SEC | ||
| Jun 16, 2023 | Jun 20, 2023 | QURE | Director | Sold | 2,280 | $18.93 | $43k | 34,119 | SEC |
| Jun 13, 2023 | Jun 20, 2023 | QURE | Director | AwardedStock Option (Right to Buy) | 17,060 | 17,060 | SEC | ||
| Jun 13, 2023 | Jun 20, 2023 | QURE | Director | Awarded | 8,700 | 36,399 | SEC | ||
| Feb 27, 2023 | Mar 1, 2023 | QURE | Director | Sold | 384 | $19.99 | $8k | 27,699 | SEC |
| Jan 3, 2023 | Jan 5, 2023 | DYAI | Director | AwardedStock Option | 79,674 | 27,174 | SEC | ||
| Nov 21, 2022 | Jan 5, 2023 | DYAI | Director | Gift | 66,300 | 6,407 | SEC | ||
| Jun 15, 2022 | Jun 17, 2022 | QURE | Director | AwardedStock Option (Right to Buy) | 17,810 | 17,810 | SEC | ||
| Jun 15, 2022 | Jun 17, 2022 | QURE | Director | Awarded | 9,080 | 28,083 | SEC | ||
| Jun 10, 2022 | Jun 14, 2022 | DYAI | Director | AwardedStock Option | 25,000 | 25,000 | SEC | ||
| Feb 28, 2022 | Mar 2, 2022 | QURE | Director | Sold | 600 | $16.76 | $10k | 19,003 | SEC |
| Feb 24, 2022 | Feb 28, 2022 | QURE | Director | AwardedStock Option (Right to Buy) | 2,645 | 2,645 | SEC | ||
| Feb 24, 2022 | Feb 28, 2022 | QURE | Director | Awarded | 1,534 | 19,603 | SEC | ||
| Jan 3, 2022 | Jan 5, 2022 | DYAI | Director | AwardedStock Option | 52,500 | 52,500 | SEC |
Page 1
Sales and notices (23)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 2, 2026 | QURE | Director | Form 4 sale | 21,167 | $983k | 44.9% | Unusual | SEC |
| Jun 30, 2026 | Jun 30, 2026 | QURE | Director | Form 144 notice | 21,167 | $983k | Notice | SEC | |
| Jun 17, 2026 | Jun 22, 2026 | QURE | Director | Form 4 sale | 5,295 | $225k | 16.9% | Routine | SEC |
| Jun 17, 2026 | Jun 17, 2026 | QURE | Director | Form 144 notice | 5,295 | $225k | Notice | SEC | |
| Jun 11, 2026 | Jun 12, 2026 | QURE | Director | Form 4 sale | 1,993 | $54k | 7.1% | No plan | SEC |
| Jun 11, 2026 | Jun 11, 2026 | QURE | Director | Form 144 notice | 1,993 | $54k | Notice | SEC | |
| Jun 3, 2026 | Jun 5, 2026 | QURE | Director | Form 4 sale | 2,645 | $79k | 11.5% | Routine | SEC |
| Jun 3, 2026 | Jun 3, 2026 | QURE | Director | Form 144 notice | 2,645 | $79k | Notice | SEC | |
| Jan 9, 2026 | Jan 12, 2026 | QURE | Director | Form 4 sale | 6,390 | $174k | 23.8% | Routine | SEC |
| Jan 9, 2026 | Jan 9, 2026 | QURE | Director | Form 144 notice | 6,390 | $174k | Notice | SEC | |
| Nov 4, 2025 | Nov 6, 2025 | QURE | Director | Form 4 sale | 38,810 | $1.2M | 65.5% | Unusual | SEC |
| Nov 4, 2025 | Nov 4, 2025 | QURE | Director | Form 144 notice | 38,810 | $1.3M | Notice | SEC | |
| Jun 20, 2025 | Jun 24, 2025 | QURE | Director | Form 4 sale | 2,112 | $31k | 9.4% | No plan | SEC |
| Jun 13, 2024 | Jun 17, 2024 | QURE | Director | Form 4 sale | 2,218 | $11k | 25.4% | Unusual | SEC |
| Jun 16, 2023 | Jun 20, 2023 | QURE | Director | Form 4 sale | 2,280 | $43k | 6.3% | No plan | SEC |
| Feb 27, 2023 | Mar 1, 2023 | QURE | Director | Form 4 sale | 384 | $8k | 1.4% | Plan not stated | SEC |
| Feb 28, 2022 | Mar 2, 2022 | QURE | Director | Form 4 sale | 600 | $10k | 3.1% | Plan not stated | SEC |
| Mar 2, 2021 | Mar 4, 2021 | QURE | Director | Form 4 sale | 504 | $19k | 2.7% | Plan not stated | SEC |
| Jan 28, 2020 | Jan 30, 2020 | QURE | Director | Form 4 sale | 806 | $50k | 5.4% | Plan not stated | SEC |
| Jan 28, 2019 | Jan 31, 2019 | QURE | Director | Form 4 sale | 1,210 | $38k | 7.5% | Plan not stated | SEC |
| Jan 29, 2018 | Jan 31, 2018 | QURE | Director | Form 4 sale | 2,878 | $53k | 18.2% | Plan not stated | SEC |
| Dec 6, 2010 | Dec 8, 2010 | KERYX BIOPHARMACEUTICALS INC | Director | Form 4 sale | 20,000 | $100k | 12.4% | Plan not stated | SEC |
| Sep 29, 2010 | Oct 1, 2010 | KERYX BIOPHARMACEUTICALS INC | Director | Form 4 sale | 25,000 | $125k | 13.4% | Plan not stated | SEC |